The success of Viagra initially drove a surge for pharma, but recent shifts present a complicated scenario for shareholders. Off-patent competitors are eroding profits, and continued legal battles add further risk to https://macieyxmy565116.diowebhost.com/96366813/the-blue-pill-and-pharma-a-precarious-bet